Stem cell patenting

Author: Baldock, Claire

Source: Journal of Commercial Biotechnology, Volume 12, Number 2, 1 January 2006 , pp. 120-126(7)

Publisher: Palgrave Macmillan

Key:

- Free Content

- New Content

- Subscribed Content

- Free Trial Content

Abstract:

The patenting of embryonic stem cell-related inventions appears to be as controversial as the technology itself. The author outlines the state of play in Europe and the USA as well as other selected territories. While Europe has the broadest statutory exclusions to patenting of inventions which might be regarded as unethical, it appears that a smooth ride for applicants and patent holders is not guaranteed elsewhere.Journal of Commercial Biotechnology (2006) 12, 120-126; doi:10.1057/palgrave.jcb.3040158

Document Type: Research article

DOI: 10.1057/palgrave.jcb.3040158

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$43.00 plus tax Refund Policy